Commentary on “Intravitreal dexamethasone implant for management of treatment-naïve retinal vein occlusion”

1. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern®. Guidelines. Bacterial Keratitis. San Francisco, CA: American Academy of Ophthalmology; 2013. Available from: http://www.aao.org/ppp. [Last accessed on 2018 Mar 02]. 2. Lalitha P, Manoharan G, Karpagam R, Pajna NV, Srinivasan M, Mascarenhas J, et al. Trends in antibiotic resistance in bacterial keratitis isolates from South India. Br J Ophthalmol 2017;101:108‐13. 3. Park J, Lee KM, Zhou H, Rabin M, Jwo K, Burton WB, et al. Community practice patterns for bacterial corneal ulcer evaluation and treatment. Eye Contact Lens 2015;41:12‐8. 4. Kowalski RP, Kowalski TA, Shanks RM, Romanowski EG, Karenchak LM, Mah FS, et al. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. Cornea 2013;32:830‐4. 5. Ofloxacin monotherapy for the primary treatment of microbial keratitis: A double‐masked, randomized, controlled trial with conventional dual therapy. The ofloxacin study group. Ophthalmology 1997;104:1902‐9. Cite this article as: Chatterjee S, Agrawal D. 5% cefuroxime as an alternative to 5% cefazolin in the treatment of Gram-positive bacterial keratitis. Indian J Ophthalmol 2018;66:1046-8.

[1]  M. Çıtırık,et al.  The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario , 2018, Indian journal of ophthalmology.

[2]  M. Zarbin.  Anti‐VEGF Agents and the Risk of Arteriothrombotic Events , 2018, Asia-Pacific journal of ophthalmology.

[3]  D. Călugăru,et al.  Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  R. Avery,et al.  Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis. , 2016, JAMA ophthalmology.

[5]  D. Roth,et al.  Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study , 2015, BMC Ophthalmology.

[6]  Y. Buys,et al.  Intraocular pressure monitoring post intravitreal steroids: a systematic review. , 2013, Survey of ophthalmology.

[7]  U. Kompella,et al.  Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. , 2011, Archives of ophthalmology.

[8]  E. Lobenhofer,et al.  Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells , 2009, BMC Medical Genomics.